Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$67.8K Buy
15,516
+3,784
+32% +$20.6K ﹤0.01% 4211
2026
Q1
$47.7K Hold
11,732
﹤0.01% 4252
2025
Q4
$150K Buy
11,732
+1,112
+10% +$16.8K ﹤0.01% 4061
2025
Q3
$182K Buy
+10,620
New +$130K ﹤0.01% 4010
2023
Q2
Sell
-154
Closed -$16.7K 4580
2023
Q1
$16.7K Buy
154
+68
+79% +$9.15K ﹤0.01% 4477
2022
Q4
$10.2K Hold
86
﹤0.01% 4572
2022
Q3
$14K Hold
86
﹤0.01% 4604
2022
Q2
$17K Hold
86
﹤0.01% 4645
2022
Q1
$32K Hold
86
﹤0.01% 4609
2021
Q4
$34K Hold
86
﹤0.01% 4650
2021
Q3
$61K Sell
86
-22
-20% -$16.8K ﹤0.01% 4497
2021
Q2
$104K Buy
+108
New +$97.6K ﹤0.01% 4356
2018
Q2
Hold
0
-$16K 4324
2018
Q1
Hold
0
4181
2017
Q4
Hold
0
4167
2017
Q3
Hold
0
4158
2017
Q2
Hold
0
4055
2017
Q1
Hold
0
3980
2016
Q4
Hold
0
4081
2016
Q3
Hold
0
4054
2016
Q2
Hold
0
4056
2016
Q1
Hold
0
4094
2015
Q4
Hold
0
4151
2015
Q3
Hold
0
4096
2015
Q2
Hold
0
3601
2015
Q1
Hold
0
3430
2014
Q4
Hold
0
3654
2014
Q3
Hold
0
3576
2014
Q2
Hold
0
3192
2014
Q1
Hold
0
3109
2013
Q4
Hold
0
3096
2013
Q3
Hold
0
3094
2013
Q2
Hold
0
3004

Other funds holding CNSY

Northern Trust's CNSY Position: Q2 2026 in Review

Northern Trust increased its Cerenome (CNSY) stake by 32% in Q2 2026, buying an estimated $20.6K and bringing the position to 15,516 shares worth $67.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4211.

Northern Trust first reported a position in CNSY in Q2 2021 and has held it in 12 quarters since. The position peaked at $182K in Q3 2025. 21 funds tracked by Wall St. Rank hold CNSY as of Q2 2026.

  • Northern Trust held 15,516 shares of Cerenome worth $67.8K as of Q2 2026.
  • Northern Trust bought 3,784 Cerenome shares in Q2 2026, an estimated $20.6K.
  • Cerenome made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4211 holding.
  • Northern Trust first reported a position in Cerenome in Q2 2021 and has held it in 12 quarters since.
  • Northern Trust's Cerenome position peaked at $182K in Q3 2025.
  • 21 funds tracked by Wall St. Rank held Cerenome as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.